Amicogen, Inc. (KOSDAQ:092040)
South Korea · Delayed Price · Currency is KRW 3,815.00
-45.00 (-1.17%)
Oct 10, 2025, 3:30 PM KST
Amicogen Market Cap
Amicogen has a market cap or net worth of 209.12 billion as of October 10, 2025. Its market cap has decreased by -21.90% in one year.
Market Cap
209.12B
Enterprise Value
311.41B
Revenue
117.72B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,815.00
Market Cap Chart
Since September 12, 2013, Amicogen's market cap has decreased from 237.19B to 209.12B, a decrease of -11.83%. That is a compound annual growth rate of -1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 209.12B | -1.17% |
| Dec 30, 2024 | 211.59B | -48.65% |
| Dec 28, 2023 | 412.06B | 8.63% |
| Dec 29, 2022 | 379.32B | -38.89% |
| Dec 30, 2021 | 620.70B | -14.98% |
| Dec 30, 2020 | 730.08B | 50.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |